As founder and CEO of the health investment company Consonance Capital, Dr. Mitchell Blutt is one of the first medical physicians to apply his expertise to the field of healthcare investment on Wall Street. Alongside his career endeavors, Mitchell Blutt, MD, maintains active membership in the New York Academy of Sciences.

1. New York Academy of Sciences
Partners With Takeda for Grant
Award
Mitchell Blutt

2. Introduction
• As founder and CEO of the health investment company Consonance
Capital, Dr. Mitchell Blutt is one of the first medical physicians to apply his
expertise to the field of healthcare investment on Wall Street. Alongside his
career endeavors, Mitchell Blutt, MD, maintains active membership in the
New York Academy of Sciences.
The New York Academy of Sciences recently announced a partnership with
the Takeda Pharmaceutical Company to fund a new research prize that will
be known as the Takeda Innovators in Science Award.
The award will be given to research projects that make a significant impact
on the treatment areas of neuroscience, gastroenterology, oncology, and
regenerative medicine.
The organization will hand out two $200,000 awards annually, with one
going to an up-and-coming researcher and the other going to a more
seasoned individual who has established himself or herself as a creative
researcher.

3. New York Academy of Sciences
• The New York Academy of Sciences will serve as
administrator for the grant program, a role that
includes handling the nomination process,
establishing judges, and creating events where the
awards will be given out. The first winners will be
announced at a ceremony set to take place at the
New York Academy of Sciences in November 2017.
To learn more about the Takeda Innovators in
Science Award, visit
http://www.nyas.org/awards/takedainnovators.asp
x.